1. Home
  2. INVE vs ASMB Comparison

INVE vs ASMB Comparison

Compare INVE & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVE
  • ASMB
  • Stock Information
  • Founded
  • INVE 1990
  • ASMB 2005
  • Country
  • INVE United States
  • ASMB United States
  • Employees
  • INVE N/A
  • ASMB N/A
  • Industry
  • INVE Computer peripheral equipment
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • INVE Technology
  • ASMB Health Care
  • Exchange
  • INVE Nasdaq
  • ASMB Nasdaq
  • Market Cap
  • INVE 87.4M
  • ASMB 93.7M
  • IPO Year
  • INVE 1997
  • ASMB 2010
  • Fundamental
  • Price
  • INVE $3.74
  • ASMB $14.49
  • Analyst Decision
  • INVE Strong Buy
  • ASMB Buy
  • Analyst Count
  • INVE 2
  • ASMB 2
  • Target Price
  • INVE $7.25
  • ASMB $35.00
  • AVG Volume (30 Days)
  • INVE 45.6K
  • ASMB 38.9K
  • Earning Date
  • INVE 03-11-2025
  • ASMB 11-07-2024
  • Dividend Yield
  • INVE N/A
  • ASMB N/A
  • EPS Growth
  • INVE N/A
  • ASMB N/A
  • EPS
  • INVE 3.10
  • ASMB N/A
  • Revenue
  • INVE $104,217,000.00
  • ASMB $28,326,000.00
  • Revenue This Year
  • INVE N/A
  • ASMB $282.16
  • Revenue Next Year
  • INVE N/A
  • ASMB N/A
  • P/E Ratio
  • INVE $1.23
  • ASMB N/A
  • Revenue Growth
  • INVE 70.57
  • ASMB N/A
  • 52 Week Low
  • INVE $2.95
  • ASMB $9.48
  • 52 Week High
  • INVE $9.24
  • ASMB $19.93
  • Technical
  • Relative Strength Index (RSI)
  • INVE 49.51
  • ASMB 40.72
  • Support Level
  • INVE $3.44
  • ASMB $14.17
  • Resistance Level
  • INVE $3.78
  • ASMB $15.73
  • Average True Range (ATR)
  • INVE 0.19
  • ASMB 1.02
  • MACD
  • INVE 0.01
  • ASMB -0.21
  • Stochastic Oscillator
  • INVE 69.77
  • ASMB 8.72

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: